
Last Posted: Apr 22, 2021
- Comprehensive tumor molecular profile analysis in clinical practice.
Özdogan Mustafa et al. BMC medical genomics 2021 14(1) 105 - Emerging genetic complexity and rare genetic variants in neurodegenerative brain diseases
F Perrone et al, Genome Medicine, April 14, 2021 - Patients' and Oncologists' Knowledge and Expectations Regarding Tumour Multigene Next Generation Sequencing: A Narrative Review.
Shirdarreh Melika et al. The oncologist 2021 - Perspective: Application of the American College of Medical Genetics Variant Interpretation Criteria to Common Variable Immunodeficiency Disorders.
Ameratunga Rohan et al. Clinical reviews in allergy & immunology 2021 - Pharmacogenomics in the Era of Next Generation Sequencing - from Byte to Bedside.
Russell Laura E et al. Drug metabolism reviews 2021 1-79 - Comprehensive analysis of germline mutations in northern Brazil: a panel of 16 genes for hereditary cancer-predisposing syndrome investigation.
Vidal Amanda Ferreira et al. BMC cancer 2021 21(1) 363 - Next-Generation Sequencing Reveals the Progression of COVID-19.
Chen Xiaomin et al. Frontiers in cellular and infection microbiology 2021 3 632490 - Barriers to Prescribing Targeted Therapies for Patients With NSCLC With Highly Actionable Gene Variants in the Veterans Affairs National Precision Oncology Program.
Vashistha Vishal et al. JCO oncology practice 2021 OP2000703 - Comparison of the diagnostic yield of aCGH and genome-wide sequencing across different neurodevelopmental disorders.
Martinez-Granero Francisco et al. NPJ genomic medicine 2021 6(1) 25 - Incidental findings in a series of 2500 gene panel tests for a genetic predisposition to cancer: Results and Impact on patients.
Nambot S et al. European journal of medical genetics 2021 104196
More
Search Result Summary
- CDC Information (9)
- NIH Information (2)
- CDC Publications (43)
- COVID-19 (109)
- Human Genome Epidemiologic Studies (2097)
- GWAS Studies (4)
- Human Genomics Translation/Implementation Studies (1493)
- Genomic Tests Evidence Synthesis (57)
- Genomic Tests Guidelines (60)
- Tier-Classified Guidelines (14)
- Non-Genomics Precision Health (7)
- Pathogen Advanced Molecular Detection (293)
- State Public Health Genomics Programs (2)
- Ethical/Legal and Social Issues (ELSI) (50)
Quick Links to Other Resources
Disclaimer: Articles listed in the Public Health Genomics and Precision Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Oct 1, 2020
- Page last updated:Apr 26, 2021
- Content source:

